T
TScan Therapeutics D
D
TCRX
6.84000
USD
-0.31
(-4.34%)
مغلق
حجم التداول
4,465
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
268,842,390
العنوان: TScan Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.